Title | Humedix Honored with `$20 Million Export Tower Award` on 61st Trade Day | ||
---|---|---|---|
Author | Master | Date | 2024-12-06 |
- Recognized for contributions to the aesthetic industry`s globalization and export growth -
Humedix, a leading aesthetic subsidiary of the Huons Group, was recognized for its outstanding export performance during the 61st Trade Day celebration in South Korea. The company announced on December 6 that it had been awarded the `$20 Million Export Tower Award` and the `Minister of Trade, Industry and Energy Award` at the event held on December 5. The Trade Day Awards, hosted annually by the Korea International Trade Association (KITA) and organized by the Ministry of South Korean Ministry of Trade, Industry and Energy, honor companies that have excelled in overseas market expansion and export growth. Humedix received the prestigious `$20 Million Export Tower Award` for its efforts to globalize South Korea`s aesthetic industry through key products like its hyaluronic acid (HA) filler, Elravie. Since establishing a dedicated international business division in December 2021, Humedix has expanded exports to 19 countries, including China and Brazil. Over the past year, the company achieved approximately $24 million (KRW 33.7 billion) in export revenue, marking a significant milestone in its global growth journey. This year`s recognition comes just four years after the company received the `$10 Million Export Tower Award` in 2020. Humedix has a history of export milestones, beginning with the `$1 Million Export Tower Award` in 2013, followed by $3 Million in 2015, $5 Million in 2017, and $10 Million in 2020. In addition to the `Export Tower Award`, Humedix also received the `Minister of Trade, Industry and Energy Award`, further cementing its reputation as a leading player in expanding exports and pioneering new international markets. Jin-Hwan Kim, CEO of Humedix, shared his aspirations for the company’s global growth, stating, “We are committed to targeting global markets with a focus on high-value aesthetic products beyond fillers. With plans to enter additional markets in the U.S. and Europe, we aim to establish Humedix as a global leader in the aesthetic industry.” Humedix has been at the forefront of the aesthetic sector with its innovative high-purity HA production technology and its signature hyaluronic acid filler, Elravie. The company also leverages its HA expertise in developing products for other medical fields, including treatments for arthritis, OTC, and ophthalmic solutions. |